Nanotechnology-targeted modulation of mitophagy in cancer therapy: Progress and challenges

Hongyu Yang1, Chang Peng1, Hanjie Sun1

  • 1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, PR China.

Acta Biomaterialia
|July 30, 2025
PubMed

Insights

Nanotechnology offers novel strategies to precisely regulate mitophagy, a cellular process vital for cancer therapy. This approach enhances mitochondrial quality control and tumor regulation, paving the way for improved cancer treatments.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Cellular Biology

Background:

  • Current cancer treatments have limited clinical efficacy, necessitating novel therapeutic targets.
  • Mitophagy, the clearance of damaged mitochondria, presents significant therapeutic potential in cancer.
  • Precise regulation of mitophagy remains a challenge in cancer therapy.

Purpose of the Study:

  • To provide a comprehensive overview of nanotechnology-based strategies for targeted mitophagy regulation in cancer therapy.
  • To discuss the mechanisms, pathways, and detection methods related to mitophagy in cancer.
  • To explore the prospects and challenges of using nanomedicine for mitophagy modulation in cancer treatment.

Main Methods:

  • Review of recent advances in nanotechnology for mitophagy regulation.
  • Analysis of nanoparticle-based drug delivery systems for targeted cancer therapy.
  • Discussion of standalone and combinatorial nanoparticle strategies.

Main Results:

  • Nanotechnology enables targeted delivery and regulation of mitophagy.
  • Nanoparticle systems offer high targeting ability and deep tissue penetration.
  • Combinatorial approaches with existing therapies show promise.

Conclusions:

  • Nanotechnology provides a promising avenue for precise mitophagy modulation in cancer.
  • Targeted mitophagy regulation via nanomedicine can improve cancer treatment efficacy.
  • Further research is needed to overcome translational and technical barriers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K